Is HPV as Primary Screening for Cervical Cancer a Changing of the Tide?
June 27, 2019 • 4:00 - 5:00 PM (Eastern)
Cervical cancer screening has had significant impact on the reduction of cervical cancers and mortality from cervical cancer in countries where screening programs have been effectively implemented. However, cervical cancer remains a significant health concern for women worldwide, and existing screening programs can still be improved upon. This webinar will discuss the history of cervical cancer screening and its shortcomings to provide context for emerging recommendations in cervical cancer screening. The use of HPV as a primary screening tool will be discussed, including the recent United States Preventative Services Task Force recommendations for cervical cancer screening.
Meredith J. Alston MD
Dr. Alston completed her undergraduate degree at the University of Colorado, and then received her medical degree from Emory University. She returned to Colorado for her residency training in Obstetrics and Gynecology at the University of Colorado. Dr. Alston is currently an Associate Professor at the University of Colorado School of Medicine and practices full-scope Obstetrics and Gynecology at Denver Health Medical Center (DHMC), the safety-net hospital system for the city and county of Denver. She became the Director of the Lower Genital Tract Disease Program for DHMC in 2012, which includes the cervical cancer screening, evaluation and management programs for approximately 30% of the residents of Denver, Colorado. Dr. Alston is also a dedicated educator and has been the Residency Program Director for the Obstetrics and Gynecology Residency Program at the University of Colorado since 2012 and Vice-Chair of Education for the Department since 2017. She is an active member of ASCCP and has served previously on the Humanitarian Committee, and is currently a member of the Education Committee.
This activity is intended for physicians, physician assistants, midwives, nurse practitioners, nurses working in obstetrics and gynecology, gynecology oncology, oncology, internal medicine, family medicine and general practice.
Upon completion of this educational activity, participants should be able to:
- Define the importance of cervical cancer screening
- Describe the evolution of cervical cancer screening
- Evaluate the strengths and shortcoming of methods of cervical cancer screening
- Detail the recommendations for HPV as a method for cervical cancer screening
As an accredited provider of CME credit, ASCCP has implemented a process to ensure that anyone who is in a position to affect the content of an educational activity has disclosed all relevant financial relationships with any commercial interest. Any conflicts of interest have been resolved by ASCCP prior to the activity.
The following person(s) disclosed no relevant financial relationships:
- Meredith J. Alston, MD – Faculty
- Peter F. Schnatz, DO - Education Committee Chair
- Kerry Curtis - Staff
- Elizabeth A. Kostas-Polston, PhD, APRN, WHNP - Education Committee Co-Chair and CME Reviewer
- Cari Price - Staff
- Alisha Yocum - Staff
This webinar is partially supported by an independent education grant from BD Diagnostics.
Continuing Medical Education (CME)
ASCCP is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA PRA Category 1 Credit(s)TM
ASCCP designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.